Altimmune submits FDA application for intranasal Covid-19 vaccine candidate
Altimmune has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to start a…
Latest News
-
10 hours
-
1 day
-
1 day
-
1 day
-
10 hours
-
1 day
-
1 day
-
1 day
Covaxx announces Covid-19 vaccine purchase deals worth $2.8bn
US company COVAXX has announced $2.8bn advanced purchase commitments of over 140 million doses of its UB-612 vaccine to be…
Latest News
View More
EU approves contract to purchase Moderna’s Covid-19 vaccine
The European Commission (EC) has approved a contract to purchase an initial 80 million doses of US biotech Moderna’s Covid-19 vaccine candidate, mRNA-1273, and has…
Companies should be free to bid on federally funded healthcare contracts: Poll
Drug products intended for the US market are increasingly being produced at offshore locations prompting legislators to call for reshoring of production. Verdict has conducted…
Joe Biden’s win and democratic control over Congress will lead to lower healthcare costs: Poll
Healthcare spending in the US is the highest among any other developed nations in the world. Verdict has conducted a…
HiFiBiO, Pharmsynthez and IBCh sign Covid-19 antibody development deal
HiFiBiO Therapeutics has entered into a partnership with Pharmsynthez and Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry RAS (IBCh) to…
Merck agrees to buy biopharma firm OncoImmune for $425m
Merck (MSD) has signed a definitive agreement to acquire all outstanding shares of clinical-stage biopharmaceutical firm OncoImmune through a subsidiary,…
AstraZeneca’s vaccine for Covid-19 shows efficacy of 90% in trials
AstraZeneca has reported that an interim analysis of clinical trials of Covid-19 vaccine candidate, AZD1222, showed one dosing regimen revealed…
Company A-Z
View More
Softigel by Procaps
Contract Pharmaceutical Development Services and Commercial Manufacturing in Advanced Softgel Technologies
SIRION Biotech
Customised Viral Vectors for Cell Modelling, Gene Therapy, and Vaccination Research and Development
Latest Content
View MoreUS elections not to impact the call for change in regulations to improve access to telemedicine: Poll
The demand for telehealth and virtual healthcare services surged due to the COVID-19 pandemic and the industry is expected to…
Medicare for all and public option for healthcare the best healthcare plan outcome of the US presidential election: Poll
The COVID-19 pandemic has made healthcare one of the top priorities for the US residents. Verdict has conducted a poll…
SenseAnywhere to Monitor Covid-19 Vaccines in Europe During Storage and Transportation
SenseAnywhere is specialised in fully automated temperature monitoring for the Pharmaceutical Industry for years already. Soon our AiroSensors, in combination…
Handling Risks and Errors in Pharma Record Webinars Part I and II
METTLER TOLEDO is pleased to announce that it will be holding its Handling Risks and Errors in Pharma Record webinar,…
Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne
Seqirus, an influenza vaccine maker, is building a new cell-based influenza vaccine manufacturing facility in Melbourne, Australia. The facility will…
Development of a Disposable Grade-A Aseptic Fill/Finish Isolation System
Isolation of aseptic processes is not a new technology. Rigid stainless-steel isolators have been available for decades and have been…